Ben Greenfield Peptides: What He Uses, His Stack, and Biohacking Protocols

Ben Greenfield is one of the most public figures in the biohacking world, and his openness about personal experimentation has introduced millions of people to peptide therapy. Over years of podcasts, books, and blog posts, Greenfield has discussed using several peptides as part of a broader longevity and performance protocol. This guide breaks down what he has shared publicly, the science behind those compounds, and the context you need to evaluate whether any of it applies to your goals.

A quick note before diving in: Greenfield shares his personal experiences as a self-experimenter and does not prescribe to others. The peptides he discusses are research compounds or require a prescription, depending on jurisdiction. Always work with a licensed physician before starting any peptide protocol.

BPC-157: The Tissue Repair Workhorse

BPC-157 (Body Protection Compound-157) is consistently one of the peptides Greenfield has mentioned most often. Derived from a protective protein found in gastric juice, BPC-157 has been studied extensively in animal models for its ability to accelerate healing of tendons, ligaments, muscle tissue, and the gut lining.

Greenfield has described using BPC-157 both systemically (via subcutaneous injection) and topically around injury sites. He has discussed it in the context of recovering from demanding athletic events — he competes in triathlons, obstacle races, and other high-output activities that accumulate significant tissue stress.

The science is promising but largely preclinical. Animal studies show BPC-157 upregulates growth hormone receptors, stimulates angiogenesis (new blood vessel formation), and modulates nitric oxide pathways. Human clinical trials are limited, though a handful of safety studies and case reports exist. For a deeper look at the compound itself, see our complete BPC-157 guide.

TB-500: Systemic Recovery at a Cellular Level

TB-500 (Thymosin Beta-4) is another compound that appears regularly in Greenfield's discussions. Where BPC-157 tends to work locally around an injury site, TB-500 exerts more systemic effects, promoting cellular migration, reducing inflammation, and supporting tissue remodeling throughout the body.

Greenfield has spoken about stacking BPC-157 and TB-500 together, which is a common combination in the peptide community. The rationale is complementary mechanisms: BPC-157 drives local angiogenesis and collagen synthesis while TB-500 mobilizes stem cells and reduces systemic inflammatory burden. For a detailed comparison of the two, see our post on best peptides for injury recovery.

In practice, the stack is typically run for 4–6 weeks during a recovery phase, then cycled off. Dosing protocols vary widely in self-reporting communities, and no standardized clinical dosing exists.

Ipamorelin: Growth Hormone Secretion Without the Side-Effect Profile

Ipamorelin is a growth hormone secretagogue — it stimulates the pituitary gland to release growth hormone (GH) in a pulsatile, physiological manner rather than flooding the body with exogenous GH. Greenfield has referenced ipamorelin as a cleaner alternative to synthetic HGH, noting it does not significantly raise cortisol or prolactin the way some other secretagogues do.

He often pairs ipamorelin with CJC-1295 (a GHRH analog), which prolongs the GH pulse. The combination is one of the most commonly discussed peptide stacks for body composition, sleep quality, and recovery. Greenfield has mentioned taking the stack before bed to capitalize on the natural overnight GH surge.

From a mechanistic standpoint, elevated GH promotes fat oxidation, lean muscle preservation, collagen synthesis, and improved sleep architecture — all relevant to both athletic performance and aging well. For more on this pairing, see our CJC-1295 peptide guide.

Epithalon: The Longevity Peptide

Greenfield is one of the more vocal public experimenters with epithalon (also spelled epitalon), a tetrapeptide originally developed by the St. Petersburg Institute of Bioregulation and Gerontology. The compound activates telomerase, the enzyme that maintains telomere length — a key marker of cellular aging.

Russian research groups have published studies showing epithalon extends lifespan in animal models, improves melatonin secretion in older subjects, and demonstrates antioxidant effects. The human data is thin by Western standards, but the mechanistic rationale is compelling enough that it has attracted serious interest from longevity researchers.

Greenfield has discussed running short epithalon courses (10–20 days) once or twice per year, in line with the original research protocols. See our best peptides for anti-aging guide for a broader longevity context.

GHK-Cu: Copper Peptide for Skin and Beyond

GHK-Cu (copper peptide) is a naturally occurring tripeptide that declines with age. Greenfield has discussed it both topically for skin repair and systemically for its broader regenerative properties. Research supports GHK-Cu's role in stimulating collagen and elastin production, activating antioxidant genes, and modulating hundreds of genes involved in tissue repair.

Greenfield's interest in GHK-Cu reflects his broader approach to aging: treating the skin as an organ worth optimizing, not just an aesthetic concern. Topical GHK-Cu serums are widely available as cosmetic products; injectable forms are in a different regulatory category.

Thymosin Alpha-1: Immune Modulation

Thymosin Alpha-1 (Ta1) is a peptide derived from the thymus gland with well-established immunomodulatory effects. It has been approved in several countries for treating hepatitis B, hepatitis C, and as an adjunct in cancer therapy. Greenfield has discussed it in the context of immune optimization and post-illness recovery.

Unlike many peptides in the biohacking space, Ta1 has a relatively robust clinical evidence base. For more, see our dedicated Thymosin Alpha-1 guide.

Greenfield's General Approach to Peptide Protocols

Several principles emerge from Greenfield's public discussions about peptides:

Cycle everything. He consistently advocates cycling peptides rather than running them indefinitely. Most of his protocols run 4–12 weeks, followed by an equal or longer break.

Stack synergistically. Rather than using a single peptide in isolation, he combines compounds with complementary mechanisms — for example, using BPC-157 locally and TB-500 systemically, or pairing ipamorelin with CJC-1295.

Work with a physician. Despite being a self-experimenter, Greenfield regularly references working with doctors who specialize in peptide therapy and regularly monitors bloodwork to track responses.

Prioritize sourcing quality. He emphasizes that peptide purity varies enormously between suppliers and advocates for pharmaceutical-grade or research-grade compounds with certificates of analysis. See our guide on why peptides are so expensive for context on cost and quality.

Start with the basics. For people new to peptides, Greenfield's entry point is usually BPC-157 for healing and ipamorelin/CJC-1295 for sleep and body composition — not the more exotic longevity compounds.

What the Evidence Actually Says

It is worth calibrating expectations here. Most of the peptides Greenfield discusses have strong animal data but limited human trials. That does not mean they are ineffective — it means the risk-benefit calculus is less certain than for FDA-approved medications. Self-experimenting biohackers like Greenfield are, in a real sense, running n=1 experiments and sharing anecdotal data.

That data has value: it helps identify which compounds seem worth investigating formally, and it builds a community knowledge base. But individual anecdotes — including those from high-profile figures — are not a substitute for randomized controlled trials. See our overview on are peptides safe for a balanced risk assessment.

Frequently Asked Questions

Q: Does Ben Greenfield recommend peptides for everyone? No. Greenfield consistently notes that his protocols are personal experiments. He recommends working with a physician experienced in peptide therapy before starting any protocol.

Q: What is the core of Ben Greenfield's peptide stack? Publicly, the most frequently mentioned compounds are BPC-157, TB-500, ipamorelin/CJC-1295, epithalon, and GHK-Cu — though the specific stack varies by goal and life phase.

Q: Are the peptides Greenfield uses legal? In the US, most are classified as research chemicals and cannot be sold for human consumption without a prescription. Legality varies by country. See our peptide legal status guide for details.

Q: Where can I find Greenfield's actual protocols? He documents his personal experiments extensively on his blog (bengreenfieldfitness.com), his podcast, and in his book Boundless. These are the primary sources to consult.

Q: Is BPC-157 the same as the pentadecapeptide form? There is a related compound called pentadecapeptide BPC. For a comparison, see our post on BPC-157 vs pentadecapeptide.